NEW YORK (GenomeWeb News) – RayBiotech said late Thursday that it has executed a master services agreement with Banner Sun Health Research Institute for the analysis of biomarkers of neurodegenerative disorders.
Under the agreement, RayBiotech will provide services for the analysis of biomarkers with a particular focus on ailments such as Alzheimer's and Parkinson diseases. The company's platform can be used to evaluate both the identity and quantity of biomarkers in a comprehensive, high-throughput manner, it said.
Financial and other terms of the deal were not disclosed.
"We believe that the collaboration will yield promising new opportunities facilitating early diagnosis of these devastating diseases," RayBiotech COO and Co-founder Rani Huang said in a statement.
The company is based in Norcross, Ga., and develops antibody and protein array technologies. Banner Sun Health is a biomedical research center headquartered in Sun City, Ariz. It conducts basic and translational research, as well as clinical research, into normal aging and certain age-related illnesses.